https://www.selleckchem.com/products/azd9291.html
This study aimed to evaluate cognitive function in patients with anxious depression. This was a part of the "Objective Diagnostic Indicators and Individualized Drug Intervention of Major Depressive Disorder (MDD)" study. All participants, including patients with MDD and healthy controls (HCs), completed the 17-item Hamilton Depression Scale (HAMD ) and the Hamilton Anxiety Scale (HAMA). Anxious depression was defined as a HAMD anxiety/somatization factor score ≥7. Cognitive function was assessed at baseline and at the end of week 8. HC
Like
Comment
Share
